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Urinary tract infections (UTIs) are among the most frequent community-acquired infections worldwide. Escherichia coli is the
most common UTI pathogen although underlying host factors such as patients’ age and gender may inﬂuence prevalence of
causative agents. In this study, 61 273 consecutive urine samples received over a 22-month period from outpatients clinics
of an urban area of north Italy underwent microbiological culture with subsequent bacterial identiﬁcation and antimicrobial
susceptibility testing of positive samples. A total of 13 820 uropathogens were isolated and their prevalence analyzed according
to patient’s gender and age group. Overall Escherichia coli accounted for 67.6% of all isolates, followed by Klebsiella pneumoniae
(8.8%), Enterococcus faecalis (6.3%), Proteus mirabilis (5.2%), and Pseudomonas aeruginosa (2.5%). Data stratiﬁcation according
to both age and gender showed E. coli isolation rates to be lower in both males aged ≥60 years (52.2%), E. faecalis and P. aeruginosa
being more prevalent in this group (11.6% and 7.8%, resp.), as well as in those aged ≤14 years (51.3%) in whom P. mirabilis
prevalence was found to be as high as 21.2%. Streptococcus agalactiae overall prevalence was found to be 2.3% although it was
shown to occur most frequently in women aged between 15 and 59 years (4.1%). Susceptibility of E. coli to oral antimicrobial
agents was demonstrated to be as follows: fosfomycin (72.9%), trimethoprim/sulfamethoxazole (72.9%), ciproﬂoxacin (76.8%),
ampicillin (48.0%), and amoxicillin/clavulanate (77.5%). In conclusion, both patients’ age and gender are signiﬁcant factors in
determining UTIs etiology; they can increase accuracy in deﬁning the causative uropathogen as well as providing useful guidance
to empiric treatment.
1.Background
Urinary tract infections (UTIs) are among the most frequent
bacterial infections worldwide [1–5]. In 2000, according to
the Urologic Diseases in America Project, UTIs accounted
f o rm o r et h a n8m i l l i o no ﬃce and 1,7 million emergency
room visits, leading to around 350000 hospitalizations [3].
In England and Wales, consulting rates in general practice
for cystitis and other urinary infections were found to be
of approximately 315 per 10000 persons [4], whereas, in
Italy, in 2002, 2.4% of a cohort of more than 450000 people
received a diagnosis of acute cystitis in primary care [5].
Although women, particularly those aged 16–64 years,
are signiﬁcantly more likely to experience UTIs than men
[4], urinary infections frequently occur in both genders and
across all age groups [3, 4]; speciﬁc populations such as
pregnant women, the elderly or patients with spinal cord
injuries, catheters,ordiabetes arealsoatincreasedrisk [6,7].
Microbial etiology of UTIs has been regarded as well
established, with E. coli being the causative pathogen in 50–
80% of cases [8, 9]; other Enterobacteriaceae (Klebsiella, Pro-
teus, Enterobacter) together with Enterococci, Streptococci,
Staphylococci, and Pseudomonas spp. account for most of
the remaining positive urine cultures [8]. Empiric antibiotic
treatment is therefore commonly adopted. However, due
to signiﬁcant local diﬀerences in frequency of urinary
agents, the emergence of new pathogens, and changes of
antimicrobial resistance, periodic evaluation of pathogens2 The Scientiﬁc World Journal
Table 1: Distribution of bacterial isolates from urine samples (n = 13820). Data are reported as number of isolates and percentages (within
brackets) of total.
Gram-negative Gram-positive
E. coli 9344 (67.6) Enterococcus spp.g 879 (6.4)
K. pneumoniaea 1217 (8.8) S. agalactiae 313 (2.3)
Proteus spp.b 734 (5.3) S. aureus 51 (0.4)
P. aeruginosa 345 (2.5) Staphylococcus spp.h 28 (0.2)
Enterobacter spp.c 295 (2.1)
K. oxytoca 239 (1.7)
Citrobacter spp.d 227 (1.6)
M. morganii 83 (0.6)
Providencia spp.e 46 (0.3)
Other Gram-negativef 19 (0.1)
All Gram-negative 12549 (90.8) All Gram-positive 1271 (9.2)
Includes: assp pneumoniae (1204 isolates) and ozaenae (13); bP. mirabilis (723) and P. vulgaris (11); cE. aerogenes (153) and E. cloacae (142); dC. koseri (180),
C. freundii (42), C. braakii (3), and C. youngae (2); eP. stuartii (38) and P. rettgeri (8); fA .b a u m a n n i i( 9 ) ,S .m a r c e s c e n s( 8 ) ,and S. maltophilia (2); gE. faecalis
(868) and E. faecium (11); hS. saprophyticus (21), S. epidermidis (4), S. haemolyticus (2), and S. warneri (1).
epidemiology is recommended, in order to revise treatment
advices[10].Sinceunderlyinghostfactorsmayaﬀecturinary
etiology and antibiotic susceptibility, speciﬁc patients groups
should be investigated in more details. Among risk factors,
patients’ gender and age can be easily accessible in sur-
veys performed at the microbiology laboratory level where
patients’ clinical features are less well known. The present
study was therefore conducted with the aim to assess UTI
etiology and antimicrobial susceptibility of a large number
of urinary pathogens isolated in an urban area of north of
Italy as well as to evaluate bacteria distribution according to
age and gender.
2. Methods
A retrospective study was performed at the Bacteriological
Laboratory of the “Centro Diagnostico Italiano” (CDI),
based in Milan (Italy), on all bacterial strains isolated
from consecutive urine samples received from outpatients
clinics of a high-populated urban area of North Italy,
between March 2008 and December 2009. Urine samples,
accompanied by microbiology request forms, were delivered
either directly to the CDI laboratory or through 7 collabo-
rating laboratories. All sample processing and patients’ data
collection were carried out centrally by the CDI laboratory.
CDI Laboratory follows Internal Quality Control proce-
dures and participates to an External Program for Quality
Assessment with positive evaluations.
As part of the routine procedure, patients received
indications to avoid antimicrobials assumption during
the previous 7days and instructions on urine sampling
(including cleaning of the genital area prior to midstream
specimen collection) and its transport to the laboratories
(within 2hours of collection). Specimens from collaborating
laboratories were transported in Vacutainer tubes containing
boric acid at 1-2% as preservative. All samples were plated as
soon as possible and no later than 24hours on Chromagar
Orientation-BD plates and incubated for 18–24hours at
37◦C. Criterion for deﬁning signiﬁcant bacteriuria (positive
samples) was the presence of ≥105 colony-forming units
(CFU)/mL of urine [11].
An automated BD Phoenix system (BD Biosciences,
USA) was used for the rapid bacteria identiﬁcation and
for the determination of antimicrobial susceptibility [12].
Phoneix AST antimicrobials panels for Gram-negative
urinary pathogens, Gram-negative nonurinary pathogens,
Streptococci, and all other Gram-positive were used.
The statistical analysis was performed by the SAS System
version 9.2. The diﬀerence between females and males in the
frequency of positive samples of each agent was analyzed by
the chi-square test. The frequency of the positive samples of
each agent as a function of gender and age groups (≤14; 15–
29; 30–59; ≥60 years) was analyzed by the logistic regression,
including in the model the terms gender, age, and the gender
by age interaction.
3. Results
A total of 61 273 urine cultures were performed over a 22-
month period; of these 13 820 (22.6%) were found to be
positiveforbacterialinfection.Nearly80%ofallisolateswere
from women (female to male ratio (F/M) = 3.8) and 58%
from subjects aged 60 years or more. Cumulatively, the two
younger age groups accounted for 11.2% of total isolates.
Female to male ratio was highest in age group 15–29 years
(F/M = 13.5) and lowest in the youngest age group (F/M =
1.4).
Overall the most frequently encountered pathogen was
Escherichia coli (67.6%), followed by Klebsiella pneumo-
niae (8.8%), Enterococcus faecalis (6.3%), Proteus mirabilis
(5.2%), Pseudomonas aeruginosa (2.5%), and Streptococcus
agalactiae (2.3%) (Table 1), all accounting for around 90%
of total isolates. Gram-negative agents represented 90.8% of
urinary pathogens.
Frequencyofisolationofallsixmainspecieswasfoundto
be statistically diﬀerent between females and males (Table 2):
E. coli, K. pneumonia, and S. agalactiae were more frequentThe Scientiﬁc World Journal 3
Table 2: Distribution of the six more frequently isolated species according to patients’ gender.
Organism All Females Males
(n = 13820) (n = 10947) (n = 2873) Pa
E. coli 9344 (67.6) 7763 (71.0) 1581 (55.0) <0.001
K. pneumonia 1217 (8.8) 995 (9.1) 209 (7.3) 0.002
E. faecalis 868 (6.3) 596 (5.4) 272 (9.5) <0.001
P. mirabilis 723 (5.2) 465 (4.2) 258 (9.0) <0.001
P. aeruginosa 345 (2.5) 149 (1.4) 196 (6.8) <0.001
S. agalactiae 313 (2.3) 270 (2.5) 43 (1.5) 0.002
All other G− 933 (6.8) 651 (5.9) 282 (9.8) <0.001
All other G+ 90 (0.7) 58 (0.5) 32 (1.1) 0.001
aP value (chi-square) of the comparison between females and males.
in females, whereas E. faecalis, P. mirabilis, and P. aeruginosa
were more common in men.
All the six most prevalent bacterial species, with the
exception of K. pneumoniae, revealed statistically signiﬁcant
diﬀerences in isolation rates within the four chosen age
groups (Table 3)w i t hE. coli being less prevalent in the
youngest subjects (58.9%) and more frequent in the age
groups 15–29 (71.0%) and 30–59 years (71.0%).
Data stratiﬁcation according to both gender and age
showed that diﬀerences in frequency of isolation between
females and males of E. faecalis and S. agalactiae were
n o tc o n s i s t e n ta c r o s sa l la g eg r o u p s( Table 3). Furthermore,
E. coli isolation rates were shown to be lower in males aged
≥60years (52.2%), whilst E. faecalis and P. aeruginosa were
shown to be more prevalent in this group (11.6% and 7.8%,
resp.), and in those aged ≤14 years (51.3%). Interestingly
P. mirabilis prevalence was found to be highest (21.2%) in
young males, aged ≤14 years.
Susceptibilitytoantimicrobialsofmainisolateduropath-
ogensisshowninTable 4.E.colisusceptibilitytoorallyactive
compounds ranged from 48.0% (ampicillin) to 97.0% (fos-
fomycin): susceptibility to trimethoprim-sulfamethoxazole
(TMP-SMX) was 72.9%. Tested quinolones compounds
resulted to be equally active against uropathogenic E. coli
(ranging from 76.6% to 77.1%), and amoxicillin/clavulanate
rate of activity (77.5%) was comparable to that of quinol-
ones. Piperacillin was the parenteral antibiotic with the
lowest rate of activity (51.9%) against E. coli; susceptibility
of E. coli to gentamicin, ceftriaxone, and cefazolin ranged
from 84.3% to 91%, while rates for piperacillin/tazobactam,
amikacin, meropenem, and imipenem were higher (from
95.4% to 100%).
K. pneumoniae susceptibility to quinolones (93.0%–
95.3%) and to TMP-SMX (89.8%) was higher in com-
parison to E. coli while fosfomycin activity resulted to be
lower (81.0%). E. faecalis susceptibility to ampicillin and
fosfomycin was high (96.1% and 100%, resp.), superior with
respect to susceptibility to quinolones (71.9%–82.3%).
S.agalactiaesusceptibilitytolevoﬂoxacinwasfoundtobe
91.1% (data not shown).
4. Discussion
As urinary tract infection is a very common disease, its
diagnosis and treatment have important implications for
patients’ health, development of antibiotic resistance, and
health care costs [1–5]. Surveillance of local UTI’s etiology
as well as of antimicrobial susceptibility is considered useful
to guide empirical therapy, as prevalence of pathogens and
their features may vary with time and geographical area
[10]. Attempts should also be made to increase prediction of
causative uropathogens through the use of demographic and
clinical available data.
Thepresentretrospectivestudydescribesthedistribution
and antimicrobial susceptibility of bacterial species isolated
from a large number of urinary samples collected over a 22-
month period, as part of routine analyses, from unselected
community patients (male and female of any age and clinical
condition) living in a urban area in the north of Italy. The
high number of available isolates allowed to stratify data
according to patients’ gender and age and so to evaluate the
association of such variables to UTI etiology.
As expected E. coli was the most frequently encountered
species in our study. Percentage of E. coli isolation (67.6%)
well compares with those reported from other outpatients
surveys conducted in north (64.6%) [13] and south (68.0%)
[14] of Italy. Other investigations conducted in Europe [15–
19] found percentages of E. coli isolation ranging from
47.6% [16] to 85.9% [19], while, in North and Latin
America, ﬁgures from 57.5% to 71.6% were reported [20,
21].Unfortunately,truediﬀerencesinlocaletiologyareoften
diﬃcult to establish due to large diﬀerences in study design,
number of samples, and patients’ entry criteria as well as in
data presentation, among diﬀerent reports.
Other frequent isolates found in this study included
K. pneumoniae, P. mirabilis, and E. faecalis, all having been
reported to be highly prevalent species in UTIs [15, 16, 20],
and P. aeruginosa and S. agalactiae whose frequency of
isolation seems to be less constant across surveys. Isolation
rates of Gram-positive bacteria other than E. faecalis and
S. agalactiae were only 0.7%; S. aureus was responsible for
0.4%ofthese,asimilarﬁndingwasobservedbyDeFrancesco
et al. in north of Italy (0.9%) in year 2005 [13].
Our study, however, showed that prevalence of urinary
pathogens following data stratiﬁcation was not consistent
across all age groups further divided by gender. Escherichia
coli, for example, was found to be less prevalent in the
youngest and oldest male subjects (51.3% and 52.2%, resp.)
and more frequent in female patients aged 15 years or older4 The Scientiﬁc World Journal
Table 3: Distribution of urine pathogens according to age groups and gender. Data are reported as number of isolates and percentages
(within brackets) of total patients in each age group.
Organism Age groups
Gender ≤14 years 15–29 years 30–59 years ≥60 years P
All 703a 841 4167 8109
Females 415 783 3615 6134
Males 288 58 552 1975
E. coli
All 414 (58.9) 597 (71.0) 2959 (71.0) 5374 (66.3) 0.0005b
Female 266 (64.1) 562 (71.8) 2591 (71.7) 4344 (70.8) < 0.0001c
Male 148 (51.3) 35 (60.3) 368 (66.7) 1030 (52.2)
K. pneumoniae
All 43 (6.1) 77 (9.2) 369 (8.6) 715 (8.8) 0.4244
Female 26 (6.3) 71 (9.1) 325 (9.0) 573 (9.3) 0.5626
Male 17 (5.9) 6 (10.3) 44 (8.0) 142 (7.2)
E. faecalis
All 18 (2.6) 45 (5.4) 258 (6.2) 547 (6.7) 0.0004
Female 14 (3.4) 42 (5.4) 222 (6.1) 318 (5.2) 0.9935
Male 4 (1.4) 3 (5.2) 36 (6.5) 229 (11.6)
P. mirabilis
All 110 (15.6) 31 (3.7) 160 (3.8) 422 (5.2) 0.0055
Female 49 (11.8) 24 (3.1) 128 (3.5) 264 (4.3) <0.0001
Male 61 (21.2) 7 (12.1) 32 (5.8) 158 (8.0)
P. aeruginosa
All 40 (5.7) 10 (1.2) 37 (0.9) 258 (3.2) <0.0001
Female 21(5.1) 6 (0.8) 19 (0.5) 103 (1.7) <0.0001
Male 19 (6.6) 4 (6.9) 18 (3.3) 155 (7.8)
S. agalactiae
All 2 (0.3) 31 (3.7) 157 (3.8) 123 (1.5) <0.0001
Female 1 (0.2) 31 (4.0) 150 (4.1) 88 (1.4) 0.0939
Male 1 (0.3) 0 (0) 7 (1.3) 35 (1.8)
apatients’ numbers; logistic regression analysis among age groups of distribution of isolation rates in bAll patients or cby Gender.
Table 4: Susceptibility rates to oral and parenteral antimicrobials of most common uropathogens isolated from urine samples.
Organism (n; %)
Antimicrobials
CIP LVX NOR NIT SXT AMP AMC FOS PIP TZP CFZ CRO MRP IMP GEN AMK
E. coli
(9344;67.6%)
76.8 77.1 76.6 95.1 72.9 48.0 77.5 97.0 51.9 95.4 84.3 90.0 100 99.9 91.0 99.6
K. pneumonia
(1204;8.7%)
93.6 93.0 95.3 35.1 89.8 0 81.4 81.0 61.8 92.3 78.3 87.9 99.7 99.9 92.9 97.1
E. faecalis
(868;8.3%)
71.9 82.3 — 96.1 — 96.1 — 100.0 — — — — — — — —
P. mirabilis
(723;5.2%)
62.9 75.2 78.3 0 51.5 38.9 67.0 60.8 64.8 98.9 65.4 79.0 100 94.0 67.7 99.3
P. aeruginosa
(345;2.3%)
57.7 58.7 60.6 0 0 0 0 0 88.4 95.9 0 0 94.7 93.3 68.0 83.7
—: not tested; CIP: ciproﬂoxacin; LVX: levoﬂoxacin; NOR: norﬂoxacin; NIT: nitrofurantoin; SXT: trimethoprim-sulfamethoxazole; AMP: ampicillin;A M C :
amoxicillin/clavulanic acid; FOS: fosfomycin; PIP: piperacillin; TZP: piperacillin/tazobactam; CFZ: cefazolin; CRO: ceftriaxone; MRP: meropenem; IMP:
imipenem; GEN: gentamicin; AMK: amikacin.
(approximately71%),Proteusmirabilisprevalencewasfound
to be highest (21.2%) in young males aged ≤14 years, whilst
S. agalactiae was mostly found in women aged between 15
and 59 years (approximately 4.0%).
Kiﬀeretal.[21]conductedastudycomparabletoours,in
terms of patient’s population (both males and females of any
age), number of isolates (35 782), and selected age groups.
They also found (1) a lower percentage of E. coli isolation in
patients younger than 13 years or older than 60 years (69.0%
and 68.8%, resp.) as compared to the age group 13–60 years
(79.7%); (2) a higher diﬀerence in E. coli rates of isolation,
between males and females, in the youngest (27.2%) and
the oldest (25.8%) age groups with respect to the 13–60
years age group (8.9%); (3) a higher prevalence of E. faecalis
(16.4%) and P. aeruginosa (14.7%) in males older than 60
years, approximately three and six times higher, respectively,
ascomparedtofemalesofthesameagegroup;(4)P. mirabilis
tobethesecondleadingcauseofUTIinpediatricpopulationThe Scientiﬁc World Journal 5
(0–13 years), accounting for 22.1% of isolates (15.6% in our
study) with a females to males ratio of 0.45 (0.55 in our
study).
Already in 1972, Bergstr¨ om [22] and, more recently,
M o d a r r e sa n dO s k o i i[ 23]r e p o r t e dP. mirabilis to be a
common cause of urinary tract infections in boys, although
this ﬁnding has not been conﬁrmed by other studies on
children UTIs [24, 25].
P. mirabilis has been described to be present in the
preputial sac of boys, having been isolated in 22.6% of
uncircumcised males of up to 14 years of age [26]; this
can support the role of P. mirabilis as an important urinary
pathogen in this group of patients. However, P. mirabilis also
seems to represent an important urinary pathogen in young
females as supported by the high isolation rates in this group
of patients observed in our study and by Kiﬀer et al. [21], in
spite of its low prevalence in the preadolescent female genital
tract ﬂora [27].
Susceptibility of uropathogenic bacteria to antimicro-
bials agents is also known to vary among countries and
over time [10]. European Urology Association (EUA)
Guidelines [6] recommend trimethoprim/sulfamethoxazole
(TMP/SMX) as ﬁrst line drug for empirical therapy in
community-acquired infections, when local rates of resis-
tance of uropathogens to TMP are <10–20%.
In our survey, 72.9% of E. coli isolates were susceptible
to TMP/SMX. Comparable ﬁgures of E. coli susceptibility to
TMP/SMX were found in Italy by De Francesco et al. (range
of70%–72%between2002and2005)[13]andMiragliottaet
al. (71.6% overall, from 2001 to 2006) [14]. Although values
may vary among reports, resistance rate of recently commu-
nity isolated of E. coli to TMP/SMX in Europe tends to be
>20% [16], having also being reported higher than 30% [28,
29]. E. coli susceptibility to ﬂuoroquinolones in our study
ranged from 76.6% (norﬂoxacin) to 77.1% (levoﬂoxacin)
which was similar to rates observed in Italy by De Francesco
etal.(78%and80%,resp.)[13]andMiragliottaetal.(78.7%
and 79.6%) [14]. E. coli susceptibility to ampicillin in our
study was found to be low (48%) and comparable to other
reports from Italy (51.0% and 44.0%) [13, 14]a n dE u r o p e
[8, 16]. Susceptibility of E. coli to amoxicillin/clavulanate
in our study was higher (77.5%) than that observed for
ampicillinandsimilartowhatrecentlyreportedfromItalyby
Miragliotta et al. (73.1%) [14] and Schito et al. (71.5%) [16],
although De Francesco et al. found even higher susceptibility
rates (90%) [13] more in line with other recent reports from
Europe [16, 19]. Among the oral antimicrobial compounds
tested in our study fosfomycin exhibited the highest activity
against E. coli (97.0%). A comparable result was shown in
a number of other studies conducted in Italy and Europe
[8, 14, 16, 30]w h e r eE. coli susceptibility to fosfomycin
ranged between 90.8% [14] and 98.1% [16].
Susceptibility to oral antimicrobials of P. mirabilis
strains isolated in our study, was generally lower than that
reported both in Italy and other countries. Susceptibility to
ciproﬂoxacin and TMP/SMX of P. mirabilis isolates in our
study was of 62.9% and 51.5%, respectively, as compared to
rates demonstrated by other authors ranging from 75.5% to
97.9% for ciproﬂoxacin and from 52.0% to 84.9% for TMP-
SMX [8, 13–16]. Similarly, rates of P. mirabilis susceptibility
to ampicillin, amoxicillin/clavulanate, and fosfomycin were
lower in this study (38.9%, 67.0%, and 68.8%, resp.), in
comparison to those described in previous reports where
ranges of susceptibility rates of 53.6%–83.9% to ampicillin,
79.6%–99.0% to amoxicillin/clavulanate, and 60.0%–96.9%
to fosfomycin were reported [8, 13–16].
In conclusion, besides providing further data on the
etiology of community-acquired UTIs and antimicrobial
susceptibility of uropathogens in Italy, our results conﬁrm
that stratiﬁcation of isolates from unselected patients on
the basis of age and gender can improve the assessment
of causative pathogens, providing guidance for empiric
treatment and interesting clues to the understanding of UTIs
etiopathology.
In particular, P. mirabilis prevalence was found to be
high both in boys (21.2%) and girls (11.8%) suggesting, as
previously reported [30], that fosfomycin could represent a
drug of choice for the therapy of children’s UTIs, especially
when considering its good antibacterial activity against both
E.coliandP. mirabilis (higherascomparedtoβ-lactams)and
the concerns on ﬂuoroquinolones use in children. For other
patients’ subgroups, it was noted that frequently isolated
bacterial species, such as E. faecalis or P. aeruginosa in
oldermales,showeddiﬀerentantimicrobialsusceptibilitiesas
compared to E. coli, underlying the importance that empiric
treatment should be based on epidemiological data which
takes into account patients gender and age.
Conﬂict of Interests
No competing interests are declared.
Acknowledgments
The authors are grateful to Patrizio Sala BSc of Data
Management and Biometry, Cremona, Italy, for his support
in data management and statistics. The reported aﬃliation
of Loredana Deﬂorio was the one at the time the study
was conducted. The ethical approval for this paper was not
required.
References
[1] A. R. Ronald, L. E. Nicolle, E. Stamm et al., “Urinary
tract infection in adults: research priorities and strategies,”
International Journal of Antimicrobial Agents,v o l .1 7 ,n o .4 ,p p .
343–348, 2001.
[2] B. Foxman, R. Barlow, H. D’Arcy, B. Gillespie, and J. D.
Sobel, “Urinary tract infection: self-reported incidence and
associated costs,” Annals of Epidemiology,v o l .1 0 ,n o .8 ,p p .
509–515, 2000.
[3] M. S. Litwin, C. S. Saigal, E. M. Yano et al., “Urologic
diseases in America project: analytical methods and principal
ﬁndings,”JournalofUrology,vol.173,no.3,pp.933–937,2005.
[4] Royal College of General Practitioners, Oﬃce of Population
Censuses and Surveys, Department of Health, Morbidity6 The Scientiﬁc World Journal
Statistics from General Practice: Fourth National Study 1991-
1992, Series MB5, no. 3, HMSO, London, UK, 1995.
[5] L. Galatti, A. Sessa, G. Mazzaglia et al., “Antibiotic prescribing
for acute and recurrent cystitis in primary care: a 4 year
descriptive study,” Journal of Antimicrobial Chemotherapy, vol.
57, no. 3, pp. 551–556, 2006.
[6] M. Grabe, M. C. Bishop, and T. E. Bjerklund-Johansen,
Guidelines on Urological Infections, European Association of
Urology, 2009.
[ 7 ]N .S h a i k h ,N .E .M o r o n e ,J .E .B o s t ,a n dM .H .F a r r e l l ,
“Prevalence of urinary tract infection in childhood: a meta-
analysis,” Pediatric Infectious Disease Journal,v o l .2 7 ,n o .4 ,p p .
302–308, 2008.
[8] G. Kahlmeter, “An international survey of the antimicrobial
susceptibility of pathogens from uncomplicated urinary tract
infections: the ECO-SENS project,” Journal of Antimicrobial
Chemotherapy, vol. 51, no. 1, pp. 69–76, 2003.
[ 9 ]D .J .F a r r e l l ,I .M o r r i s s e y ,D .d eR u b e i s ,M .R o b b i n s ,a n dD .
Felmingham, “A UK multicentre study of the antimicrobial
susceptibility of bacterial pathogens causing urinary tract
infection,” Journal of Infection, vol. 46, no. 2, pp. 94–100, 2003.
[10] D. M. Livermore and A. Pearson, “Antibiotic resistance: loca-
tion, location, location,” Clinical Microbiology and Infection,
vol. 13, supplement 2, pp. 7–16, 2007.
[11] E. H. Kass, “Bacteriuria and the diagnosis of infections of the
urinary tract with observations on the use of methionine as a
urinary antiseptic,” Archives of Internal Medicine, vol. 100, pp.
709–714, 1957.
[12] A. M. Fahr, U. Eigner, M. Armbrust et al., “Two-center
collaborative evaluation of the performance of the BD
Phoenix Automated Microbiology System for identiﬁcation
and antimicrobial susceptibility testing of Enterococcus spp.
and Staphylococcus spp,” Journal of Clinical Microbiology, vol.
41, no. 3, pp. 1135–1142, 2003.
[13] M. A. De Francesco, G. Ravizzola, L. Peroni, R. Negrini, and
N. Manca, “Urinary tract infections in Brescia, Italy: etiology
of uropathogens and antimicrobial resistance of common
uropathogens,” Medical Science Monitor,v o l .1 3 ,n o .6 ,p p .
BR136–BR144, 2007.
[14] G. Miragliotta, M. N. Di Pierro, L. Miragliotta, and A. Mosca,
“Antimicrobial resistance among uropathogens responsible
for community-acquired urinary tract infections in an Italian
community,” Journal of Chemotherapy, vol. 20, no. 6, pp. 721–
727, 2008.
[15] R. Daza, J. Guti´ errez, and G. Pi´ edrola, “Antibiotic susceptibil-
ity of bacterial strains isolated from patients with community-
acquired urinary tract infections,” International Journal of
Antimicrobial Agents, vol. 18, no. 3, pp. 211–215, 2001.
[16] G. C. Schito, K. G. Naber, H. Botto et al., “The ARESC
study: an international survey on the antimicrobial resistance
of pathogens involved in uncomplicated urinary tract infec-
tions,” International Journal of Antimicrobial Agents, vol. 34,
no. 5, pp. 407–413, 2009.
[17] F. W. Goldstein, “Antibiotic susceptibility of bacterial strains
isolated from patients with community-acquired urinary tract
infectionsinFrance,”EuropeanJournalofClinicalMicrobiology
and Infectious Diseases, vol. 19, no. 2, pp. 112–117, 2000.
[18] D. J. Farrell, I. Morrissey, D. de Rubeis, M. Robbins, and D.
Felmingham, “A UK multicentre study of the antimicrobial
susceptibility of bacterial pathogens causing urinary tract
infection,” Journal of Infection, vol. 46, no. 2, pp. 94–100, 2003.
[19] L. S. Stratchounski and V. V. Rafalski, “Antimicrobial sus-
ceptibility of pathogens isolated from adult patients with
uncomplicated community-acquired urinary tract infections
in the Russian Federation: two multicentre studies, UTIAP-1
and UTIAP-2,” International Journal of Antimicrobial Agents,
vol. 28, supplement 1, pp. 4–9, 2006.
[20] G. G. Zhanel, T. L. Hisanaga, N. M. Laing et al., “Antibiotic
resistance in Escherichia coli outpatient urinary isolates: ﬁnal
results from the North American Urinary Tract Infection
Collaborative Alliance (NAUTICA),” International Journal of
Antimicrobial Agents, vol. 27, no. 6, pp. 468–475, 2006.
[21] C. R. V. Kiﬀe r ,C .M e n d e s ,C .P .O p l u s t i l ,a n dJ .L .S a m p a i o ,
“Antibiotic resistance and trend of urinary pathogens in
general outpatients from a major urban city,” International
Brazilian Journal of Urology, vol. 33, no. 1, pp. 42–48, 2007.
[22] T. Bergstr¨ om, “Sex diﬀerences in childhood urinary tract
infection,” Archives of Disease in Childhood, vol. 47, no. 252,
pp. 227–232, 1972.
[23] S. Modarres and N. N. Oskoii, “Bacterial etiologic agents of
urinary tract infection in children in the Islamic Republic of
Iran,” Eastern Mediterranean Health Journal,v o l .3 ,n o .2 ,p p .
290–295, 1997.
[ 2 4 ] K .A .F e d l e r ,D .J .B i e d e n b a c h ,a n dR .N .J o n e s ,“ A s s e s s m e n to f
pathogen frequency and resistance patterns among pediatric
patient isolates: report from the 2004 SENTRY Antimicrobial
Surveillance Program on 3 continents,” Diagnostic Microbiol-
ogy and Infectious Disease, vol. 56, no. 4, pp. 427–436, 2006.
[25] S. Y¨ uksel, B. Ozt¨ urk, A. Kavaz et al., “Antibiotic resistance
of urinary tract pathogens and evaluation of empirical
treatment in Turkish children with urinary tract infections,”
International Journal of Antimicrobial Agents,v o l .2 8 ,n o .5 ,p p .
413–416, 2006.
[26] J. Glennon, P. J. Ryan, C. T. Keane, and J. P. R. Rees,
“Circumcision and periurethral carriage of Proteus mirabilis
in boys,” Archives of Disease in Childhood,v o l .6 3 ,n o .5 ,p p .
556–557, 1988.
[27] A. Jaquiery, A. Stylianopoulos, G. Hogg, and S. Grover,
“Vulvovaginitis: clinical features, aetiology, and microbiology
of the genital tract,” Archives of Disease in Childhood, vol. 81,
no. 1, pp. 64–67, 1999.
[28] D. C. Bean, D. Krahe, and D. W. Wareham, “Antimicrobial
resistance in community and nosocomial Escherichia coli
urinary tract isolates, London 2005-2006,” Annals of Clinical
Microbiology and Antimicrobials, vol. 7, article 13, 2008.
[29] O. Guneysel, O. Onur, M. Erdede, and A. Denizbasi,
“Trimethoprim/sulfamethoxazole resistance in urinary tract
infections,” Journal of Emergency Medicine,v o l .3 6 ,n o .4 ,p p .
338–341, 2009.
[30] B.J .K nottnerus,S.N ys,G.T erRiet,G.Donk er ,S.E.Geerlings,
and E. Stobberingh, “Fosfomycin tromethamine as second
agent for the treatment of acute, uncomplicated urinary
tract infections in adult female patients in The Netherlands?”
Journal of Antimicrobial Chemotherapy, vol. 62, no. 2, pp. 356–
359, 2008.